Tuesday 25 September 2012 | |
Opening Ceremony Keynote Presentation |
|
18:00-18:15 |
Welcome Address - Bernard Vallat, Directeur Général, |
18:15-18:30 | Program Review - Objectives and Expected Outcomes |
18:30-19:00 | Keynote Presentation |
19:00-20:00 | Reception (TBD) |
Wednesday 26 September 2012 | |
SESSION 1
|
|
09:00-09:30 | Antimicrobials in Animal Health - Lessons from Nature |
09:30-10:00 | Avian cathelicidins: paradigms for the development of anti-infectives |
10:00-10:30 | Animal-derived Antimicrobial Peptides and Swine Health |
10:30-11:00 | Coffee Break: Session 1 Posters |
11:00-11:20 | Prebiotics and Probiotics in Animal Production: Present Status and Future Perspectives |
11:20-11:40 | Heavy metals as alternatives to antibiotics: Panacea or Pandora´s Box? |
11:40-12:00 | Bacteriophages the alternatives to antibiotics for animal feed |
12:00-12:45 | Session 1 Expert Panel Discussion: Review novel alternatives to antibiotics from nature and discuss what is needed to develop them |
12:45-14:00 | Lunch: Session 1 Posters |
SESSION 2
|
|
14:00-14:30 | Selective modulators of innate immunity for anti-infective therapy to replace or supplement antibiotics |
14:30-15:00 | Novel anti-infective molecule from innate immune cells as an antibiotic-alternative to control infections caused by Apicomplexa |
15:00-15:30 | Control and Prevention of Antibiotic-Resistant Infections by a Host Defense Peptide through Modulation of Innate Immunity |
15:30-16:15 | Coffee Break: Session 2 Posters |
16:15-16:45 | Evaluation of an interleukin-2 treatment for prevention of intramammary infections in cows after calving Massimo Amadori Laboratory of Cellular Immunology, Istituto Zooprofilattico Sperimentale della Lombardia e dell´ Emilia-Romagna, Brescia, Italy |
16:45-17:15 | Biotherapeutics as Alternatives to Antibiotics: Effect of IFN-α and G-CSF on Innate and Adaptive Immunity in Swine |
17:15-18:00 | Session 2 Expert Panel Discussion: Review novel immune intervention strategies to replace or complement antibiotics for disease prevention and treatment and discuss what is needed to develop them. |
Thursday 27 September 2012 | |
SESSION 3
|
|
09:00-09:30 | The role of the microbiota in enteric diseases and allergies |
09:30-10:00 | The ruminal microbiome and animal health |
10:00-10:30 | The ruminal virome |
10:30-11:00 | Coffee Break: Session 3 Posters |
11:00-11:30 | |
The chicken intestinal microbiome as a target for improving productivity |
|
11:30-12:00 | Impact of age and intestinal microbiota on the expression of avian defensins in the chicken gut |
12:00-12:45 | Session 3 Expert Panel Discussion: Review novel technologies derived from the gut microbiome and discuss what is needed to develop them |
12:45-14:00 | Lunch: Session 3 Posters |
SESSION 4
|
|
14:00-14:30 | Looking outside the box: Present and future perspective for alternatives to antimicrobial growth promoters in livestock and poultry |
14:30-15:00 | Alternatives to antibiotics as growth promotants for dairy and beef cattle: Mechanisms of action and field performance |
15:00-15:30 | Intestinal Microbiota Associated with High Feed Conversion Efficiency in Chickens |
15:30-16:15 | Coffee Break: Session 4 Posters |
16:15-16:35 | Cinnamaldehyde Enhances In Vitro Parameters of Immunity and Augments In Vivo Protection Against Avian Coccidiosis |
16:35-16:55 | Effect of Dietary Protein and Protease Supplementation on Performance and Gut Health of Broiler Chicks |
16:55-17:15 | Identification of Bile Salt Hydrolase Inhibitors, Promising Alternative to Antibiotic Growth Promoters |
17:15-18:00 | Session 4 Expert Panel Discussion: Review alternatives to antibiotics for growth promotion and discuss what is needed to develop them |
Friday, 28 September 2012 | |
SESSION 5
|
|
09:00-09:30 | FDA´s innovation initiative to evaluate novel emerging technologies and international cooperation in the area of innovation |
09:30-10:00 | European approach to authorization of novel technologies with particular emphasis on alternatives to antibiotics |
10:00-10:30 | Coffee Break |
10:30-11:00 | National approach in China to authorization of alternatives to antibiotics |
11:00-11:30 | Challenges of gaining regulatory approval in the different regions when moving new molecules from discovery to production |
11:30-12:00 | Seeking regulatory approval for a claim new to regulatory science - "This product reduces the use of antibiotics" |
12:00-13:00 | Lunch |
13:00-14:00 | Session 5 Expert Panel Discussion: Review regulatory pathways and discuss industry needs to support the development of alternatives to antibiotics |
14:00-14:30 | Conclusion and Next Steps |